Dr. James L Gulley MD PHD FACP
Hematologist-Oncologist | Hematology & Oncology
10 Center Dr. 8b08, Msc 1750 Bethesda MD, 20892Rating
5/5
About
Dr. James Gulley is a hematologist oncologist practicing in Bethesda, MD. Dr. Gulley specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- A novel ELISPOT assay to enhance detection of antigen-specific T cells employing antigen-presenting cells expressing vector-driven human B7-1.
- The clinical effects of chlorpromazine in cerebral palsy.
- Strategies for the development of PSA-based vaccines for the treatment of advanced prostate cancer.
- A phase I study of oral CC-5013 (lenalidomide, Revlimid), a thalidomide derivative, in patients with refractory metastatic cancer.
- Vaccine therapy for a patient with androgen-insensitive prostate cancer without evidence of measurable disease on scans.
- Analyses of recombinant vaccinia and fowlpox vaccine vectors expressing transgenes for two human tumor antigens and three human costimulatory molecules.
- Therapeutic vaccines for prostate cancer: a review of clinical data.
- Antiandrogen, vaccine and combination therapy in patients with nonmetastatic hormone refractory prostate cancer.
- A retrospective study of the time to clinical endpoints for advanced prostate cancer.
- A randomized phase II study of concurrent docetaxel plus vaccine versus vaccine alone in metastatic androgen-independent prostate cancer.
- Docetaxel-based regimens, the standard of care for metastatic androgen-insensitive prostate cancer.
- Therapeutic vaccines for prostate cancer.
- A pilot trial of a carcinoembryonic antigen/ TRICOM-based vaccine and radiation to liver metastases in patients with carcinoembryonic antigen-positive solid tumors.
- A randomized phase II study of docetaxel alone or in combination with PANVAC-V (vaccinia) and PANVAC-F (fowlpox) in patients with metastatic breast cancer (NCI 05-C-0229).
- A phase I feasibility study of an intraprostatic prostate-specific antigen-based vaccine in patients with prostate cancer with local failure after radiation therapy or clinical progression on androgen-deprivation therapy in the absence of local defin
Clinical Trials
- Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate Cancer
- MSB0011359C (M7824) in Metastatic or Locally Advanced Solid Tumors
- A Trial of CV301 in Combination With Anti-PD-1 Therapy Versus Anti-PD-1 Therapy in Subjects With Non-Small Cell Lung Cancer
Dr. James L Gulley MD PHD FACP's Practice location
Dr. James Gulley
10 Center Dr. 8b08, Msc 1750 -Bethesda, MD 20892Get Direction
Dr. James L Gulley MD PHD FACP's reviews
Write ReviewPatient Experience with Dr. Gulley
Recommended Articles
![]()
Boy Who Donated Hair to Kids with Cancer Fights Stage Four LymphomaTorrin Breneman first learned about cancer three years ago, and it made an impact on him. When he learned what cancer can do to a person, and that it affects children across the world, Torrin made a decision to do something about it. He grew out his hair for the next three years, with the intentions...
![]()
The Promising Future of Gene Therapy and LymphomaNon-Hodgkin lymphoma affects over 700,000 people in America alone. Though current treatments are moderately effective, especially for aggressive forms of the disease, more can be done to help people impacted by NHL. Researchers are doing just that by working to develop new, innovative treatment for...
![]()
7-year-old with Lymphoma Joins and Inspires Lacrosse TeamSports have a way of bringing together families, strangers, and communities. All over the world people celebrate games and competitions and use them to lift people’s spirits and strengthen bonds. Sporting events are also frequently used to raise awareness about important causes, whether locally or...
![]()
Morphos Declared a "Breakthrough Therapy" for LymphomaMorphoSys’s main objective is to design exceptional and unique biopharmaceuticals, all designed to enhance the lives of patients suffering from severe or life-threatening conditions.The human body has two types of lymphocytes that can develop into lymphomas: B lymphocytes (B cells) and T...
![]()
The Leukemia & Lymphoma Society to Expand Mission Against Blood CancerOn July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
![]()
Teen Finds Strength to Give Back After Battling LymphomaAyden Mills is a 14-year-old middle school student residing in Vancouver, Washington. It’s easy to wonder how someone could be an inspiration at such a young age, but what Mills has gone fought through is nothing short of amazing. Mills’s story shows how it is possible to fight through even the...
Nearby Providers
![]()
Dr. Jacinta D. Elder M.D.10 Crc Rm 1341 Bethesda MD 20892![]()
Ronald Gress M.D.Building 10 - Hatfield CRC, Bethesda MD 20892![]()
Dr. Robert Sokolic M.D.10 Center Dr Bethesda MD 20892![]()
Dr. Yong Tang M.D.9000 Rockville Pike Bethesda MD 20892![]()
Dr. Jeremy Mark Pantin M.D.10 Center Drive Msc 1202 Bethesda MD 20892![]()
Dr. Henry Colburn Stevenson-perez M.D.Nci-Navy Medical Oncology Bethesda MD 20892
Nearest Hospitals
SIBLEY MEMORIAL HOSPITALl
5255 LOUGHBORO RD NW WASHINGTON DC 20016HOLY CROSS HOSPITALl
1500 FOREST GLEN ROAD SILVER SPRING MD 20910SUBURBAN HOSPITALl
8600 OLD GEORGETOWN ROAD BETHESDA MD 20814